Aspirin plus rivaroxaban to prevent clots after hip fracture surgery
Treatments studied
Part of Injuries & trauma clinical trials.
This trial studies which pill regimen helps prevent dangerous blood clots after hip fracture surgery. You might be eligible if you’re 50 or older and can start treatment soon after your injury.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 50 or older and arrived at the hospital within 24 hours of the hip fracture
- Your hip fracture is a type that doctors plan to fix with surgery
- You may be taking aspirin or clopidogrel (anti-platelet medicines) before the fracture
- You can provide consent (or a legal substitute can) and agree to follow-up visits
- You can take aspirin and rivaroxaban if needed (no allergy and no certain bleeding risks or kidney failure)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two approaches for preventing blood clots in older adults who broke a hip. The goal is to find the safest and most effective way to manage clot risk after surgery.
This study looks at whether fixing a hip fracture sooner is better for people who take a direct oral anticoagulant (DOAC) blood thinner. It compares early surgery versus delayed surgery in people whose delay is specifically from the blood thinner.
This study compares two ways to lower the risk of blood clots in people who had hip surgery and also had a slight heart injury. You will receive either a standard blood thinner (rivaroxaban) plus aspirin, or just aspirin alone, to see which works better without extra risk.
This study tests a shorter course of blood thinner medication (rivaroxaban) after hip replacement surgery, following an enhanced recovery plan. It aims to see if a shorter treatment can safely prevent blood clots and help you recover faster.
This trial compares two ways to prevent blood clots in people with severe leg blockage (chronic limb-threatening ischemia) who are not having surgery. It tests aspirin alone versus a newer blood thinner (rivaroxaban) plus aspirin, to see which works better in preventing complications.
This trial compares two blood-thinning strategies after leg artery surgery or angioplasty to prevent dangerous blood clots. Participants will receive either rivaroxaban plus aspirin or aspirin alone, and researchers will monitor for clots over 30 days.
Hear when a new Hip Fractures trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.